{
  "metadata": {
    "case_id": 60,
    "model": "Gemini-3-Pro",
    "timestamp": "2025-11-29T17:42:16.540467",
    "total_alignments": 5,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/60_NCT04124536.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Gemini-3-Pro/60_Gemini-3-Pro.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.identificationModule.secondaryIdInfos",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.95
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "id": "R01AI131060",
            "type": "NIH",
            "link": "https://reporter.nih.gov/quickSearch/R01AI131060"
          },
          "pred_item": {
            "id": "R01 AI131060",
            "type": "NIH",
            "domain": "National Institute of Allergy and Infectious Diseases (NIAID)"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.4,
          0.94
        ],
        [
          0.88,
          0.65
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.94,
          "status": "matched",
          "ref_item": {
            "label": "Intervention",
            "type": "EXPERIMENTAL",
            "description": "In addition to standard partner notification services, the intervention arm will receive HIV self-test kits and structured counseling about HIVST, regardless of HIV status.",
            "interventionNames": [
              "Behavioral: HIV self-testing with partner notification."
            ]
          },
          "pred_item": {
            "label": "Intervention Group",
            "type": "EXPERIMENTAL",
            "description": "Participants received partner notification services (same options as Control) plus targeted education on the use of oral HIV self-test kits and secondary distribution of up to five oral HIV self-test kits.",
            "interventionNames": [
              "Partner Notification Services",
              "HIV Self-Test Kits"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 0,
          "score": 0.88,
          "status": "matched",
          "ref_item": {
            "label": "Control",
            "type": "NO_INTERVENTION",
            "description": "Standard partner notification services, regardless of HIV status."
          },
          "pred_item": {
            "label": "Control Group",
            "type": "ACTIVE_COMPARATOR",
            "description": "Participants received partner notification services only. This included an adapted version for women who were HIV-negative. Participants were offered four options for male partner HIV testing: client self-referral, provider contract referral, provider referral, and dual referral.",
            "interventionNames": [
              "Partner Notification Services"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.74,
          0.86
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.86,
          "status": "matched",
          "ref_item": {
            "type": "BEHAVIORAL",
            "name": "HIV self-testing with partner notification.",
            "description": "HIV self-test kits are oral swabs. Partner notification will be offered to all women in the intervention arm, regardless of HIV status.",
            "armGroupLabels": [
              "Intervention"
            ]
          },
          "pred_item": {
            "type": "DIAGNOSTIC_TEST",
            "name": "HIV Self-Test Kits",
            "description": "Secondary distribution of up to five oral HIV self-test kits (OraQuick, Orasure Technologies) provided to the pregnant woman for use by her partner and herself, accompanied by targeted education on their use.",
            "armGroupLabels": [
              "Intervention Group"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.97
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.97,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Who Reported Primary Male Partner Completed HIV Testing at a Healthcare Facility",
            "description": "The number of participants who report their primary male partners getting tested for HIV at a healthcare facility when presented with partner notification plus secondary distribution of HIV self-test kits compared to partner notification alone",
            "timeFrame": "Enrollment - 30 days post enrollment of study participant"
          },
          "pred_item": {
            "measure": "Proportion of primary male partners reported to have tested for HIV at a health facility",
            "description": "Testing at a health-care facility emphasizes the importance of HIV testing by trained personnel and the need for engaging with HIV services. The outcome relied on the female participant's report.",
            "timeFrame": "Within 30 days of randomisation"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.secondaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 4,
      "pred_count": 3,
      "similarity_matrix": [
        [
          0.78,
          0.78,
          0.25
        ],
        [
          0.2,
          0.25,
          0.86
        ],
        [
          0.07,
          0.25,
          0.19
        ],
        [
          0.22,
          0.58,
          0.18
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.78,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Who Reported HIV Testing With Primary Male Partner at a Healthcare Facility",
            "description": "The number of couples getting tested for HIV when presented with partner notification plus secondary distribution of HIV self-test kits will be compared to partner notification alone.",
            "timeFrame": "Enrollment - 30 days post enrollment of study participant"
          },
          "pred_item": {
            "measure": "Proportion of primary male partners reported to have HIV testing of any kind",
            "description": "Includes HIV self-testing in the household and other community-based venues.",
            "timeFrame": "Within 30 days of randomisation"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 2,
          "score": 0.86,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Reporting Social Harms",
            "description": "The number of participants reporting social harms associated with the HIV testing approaches. Participants were asked about social harms related to trial participation, including perceived stigma, discrimination, and intimate partner violence.",
            "timeFrame": "Enrollment - 30 days post enrollment of study participant"
          },
          "pred_item": {
            "measure": "Incidence of social harms and intimate partner violence",
            "description": "An affirmative response to any question on either the social harms or intimate partner violence instruments administered at follow-up was counted as an incident social harm or intimate partner violence event.",
            "timeFrame": "At the 30 day follow-up visit"
          }
        },
        {
          "ref_idx": 2,
          "pred_idx": null,
          "score": null,
          "status": "padded",
          "ref_item": {
            "measure": "Number of Healthcare Providers Describing Feasibility of Intervention Via In-depth Interviews (Qualitative)",
            "description": "To gain deeper insights about the feasibility of male partner HIV testing strategies, healthcare workers from the study site were asked to participate in in-depth interviews. Participating healthcare workers were involved in different aspects of male partner HIV testing and included study staff members. Feasibility was defined as a positive rating about the intervention's potential performance in real-life conditions at the clinic and community levels.",
            "timeFrame": "6 months after the start of enrollment"
          },
          "pred_item": null
        },
        {
          "ref_idx": 3,
          "pred_idx": 1,
          "score": 0.58,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants Describing Acceptability of Intervention Via In-depth Interviews (Qualitative)",
            "description": "To gain deeper insights about the acceptability of the different male partner HIV testing strategies, subsamples of participants were selected based on study arm (intervention vs. control) and woman's HIV status (positive vs. negative). For the outcome measure, acceptability was defined as a positive rating of male partner HIV testing strategies from participants based on their experiences.",
            "timeFrame": "In the first two months of enrollment"
          },
          "pred_item": {
            "measure": "HIV test results of male partners",
            "description": "For those women whose main partner had been tested for HIV, the results of the HIV test were reported.",
            "timeFrame": "Within 30 days of randomisation"
          }
        }
      ]
    }
  ]
}